Chitosans inhibit the growth and the adhesion of Klebsiella pneumoniae and Escherichia coli clinical isolates on urinary catheters

被引:29
|
作者
Campana, Raffaella [1 ]
Casettari, Luca [1 ]
Ciandrini, Eleonora [2 ]
Illum, Lisbeth [3 ]
Baffone, Wally [1 ]
机构
[1] Univ Urbino Carlo Bo, Dept Biomol Sci, I-61029 Urbino, Italy
[2] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[3] IDentity, 19 Cavendish Crescent North, Nottingham NG7 1BA, England
关键词
Antimicrobial activity; Chitosans; Catheter-associated urinary tract infection (CAUTI); ANTIBACTERIAL ACTIVITY; MOLECULAR-WEIGHT; TRACT-INFECTIONS; PATHOGENESIS; ACETYLATION; PREVENTION; BIOFILM; WALL;
D O I
10.1016/j.ijantimicag.2017.03.031
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The aim of this study was to determine the antimicrobial activity of different chitosans (CS) against typical colonizing pathogens of the urinary tract and to assess their efficacy against bacterial adhesion and the subsequent biofilm formation on urinary catheters. Methods: The antimicrobial activity of high and low molecular weight CS (50 and 150 kDa) at pH 5.0 and 6.0 was tested against Klebsiella pneumoniae and Escherichia coli clinical isolates by time-kill studies. The anti-adhesion assays on Foley urinary catheters were performed in Artificial Urine Medium (AUM) with the addition of each CS (AUM-CS) at the same pH values. Finally, the efficacy over time of chitosan treatments on bacterial adhesion on urinary catheters was determined. Results: A viability reduction of K. pneumoniae and E. coli isolates, regardless of pH value, was evidenced in time-kill studies, in particular in the presence of CS 50 kDa. As regards the anti-adhesion efficacy on urinary catheters, high and low molecular weight CS evidenced a higher efficacy to reduce bacterial adhesion at pH 5.0. A low number of viable K. pneumoniae and E. coli cells were recovered from catheters after CS treatments, highlighting a promising efficacy over time. Conclusion: Our data show the potential of chitosans to reduce or prevent not only the adhesion of well-known human uropathogens on urinary catheters but also the re-growth ability of the uropathogens. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 50 条
  • [1] Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae
    Daoud, Ziad
    Sokhn, Elie Salem
    Azar, Eid
    Masri, Khalil
    Doron, Shira
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (02): : 154 - 159
  • [2] Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates
    Yuan, Jinyi
    Xu, Xiaogang
    Guo, Qinglan
    Zhao, Xu
    Ye, Xinyu
    Guo, Yan
    Wang, Minggui
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) : 1655 - 1659
  • [3] TRANSFERABLE RESISTANCE TO CEFTAZIDIME IN CLINICAL ISOLATES OF KLEBSIELLA PNEUMONIAE AND ESCHERICHIA-COLI
    VERSCHRAEGEN, G
    VUYE, A
    CLAEYS, G
    ACTA CLINICA BELGICA, 1988, 43 (05): : 356 - 361
  • [4] Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae
    Rodriguez-Navarro, Judith
    Miro, Elisenda
    Brown-Jaque, Maryury
    Carlos Hurtado, Juan
    Moreno, Albert
    Muniesa, Maite
    Jose Gonzalez-Lopez, Juan
    Vila, Jordi
    Espinal, Paula
    Navarro, Ferran
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [5] Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway
    Lindemann, Paul Christoffer
    Risberg, Kine
    Wiker, Harald G.
    Mylvaganam, Haima
    APMIS, 2012, 120 (06) : 495 - 502
  • [6] EVALUATION OF EXTENDED SPECTRUM beta-LACTAMASE (ESBL) IN URINARY ISOLATES OF ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
    Purohit, Manish
    Mutha, Anita
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (01): : 19 - 22
  • [7] URINARY ISOLATES OF APRAMYCIN-RESISTANT ESCHERICHIA-COLI AND KLEBSIELLA-PNEUMONIAE FROM DUBLIN
    JOHNSON, AP
    MALDE, M
    WOODFORD, N
    CUNNEY, RJ
    SMYTH, EG
    EPIDEMIOLOGY AND INFECTION, 1995, 114 (01): : 105 - 112
  • [8] A novel parC mutation potentiating fluoroquinolone resistance in Klebsiella pneumoniae and Escherichia coli clinical isolates
    Yakout, Marwa Atef
    Ali, Ghada Hani
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (02): : 314 - 319
  • [9] Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates
    Hadziyannis, E
    Tuohy, M
    Thomas, L
    Procop, GW
    Washington, JA
    Hall, GS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (02) : 113 - 117
  • [10] Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae
    Kaur, Jaspal
    Chopra, Shashi
    Sheevani
    Mahajan, Gomty
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (02) : 229 - 233